Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2005
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979468 Oral composition and method for the treatment of inflammatory cutaneous disorders
12/27/2005US6979463 Stable extended release oral dosage composition
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2117257C Alginate-containing wound dressing
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005120575A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation
12/22/2005WO2005120572A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
12/22/2005WO2005120555A1 Use of human lysozyme in preparation of medicine for treating acne
12/22/2005WO2005120487A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282843 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282788 Pharmaceutical compositions comprising silicones and two solubilized active principles
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050281900 Plant extract of the species Vitis vinifera as no-synthase inhibitor and uses
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281764 Use of EGF-R protein tyrosine kinase inhibitors for preventing photoaging in human skin
12/22/2005US20050281755 Topical foam/mousse compositions for treating psoriasis
12/22/2005US20050281749 Sprayable compositions comprising a combination of pharmaceutical actives and an oily phase
12/22/2005DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2568744A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
12/21/2005EP1607098A1 Cosmetic use of an active ingredient that increases Gadd45 gene expression
12/21/2005EP1607095A1 Antipruritic composition for external use on skin
12/21/2005EP1606625A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
12/21/2005EP1606260A1 Oxamide derivatives useful as raf-kinase inhibitors
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605945A1 Topical formulation and use of buspirone
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1450834B1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1282429A4 Pharmaceutical gel composition
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1250161B1 Polymer blends as biodegradable matrices for preparing biocomposites
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP0975766B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1711095A Composition for restoring damaged skin
12/21/2005CN1232535C GST fusion expression of conotoxin MVII A gene and its use
12/21/2005CN1232532C Fibroblast growth factor-2 analogue, producing process and application thereof
12/21/2005CN1232531C Production process and use of epidermal cell chalone
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232294C Externally applied Chinese medicinal composition for treating onychomycosis and its preparing process
12/21/2005CN1232287C Chinese medicinal preparation for treating sicca syndrome and its preparing method
12/21/2005CN1232286C Medication for treating hemorrhoids and preparation method
12/21/2005CN1232282C Tincture for pain-relieving, inflammation-diminishing, decay-eliminating and tissue regeneration
12/21/2005CN1232269C Chinese medicinal external-use oil preparation for treating skin swelling and ulcer
12/21/2005CN1232263C Medication containing rare earth for treating skin disease and preparation method
12/20/2005US6977302 useful in treatment of fungal infections in humans and other mammals
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117890A2 Thienopyrimidines and thiazolopyrimidines for use in medicine
12/15/2005WO2005117852A1 Composition for treatment of a hydrofluoric acid burn
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277597 Use of N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester to treat sunburn and other burns
12/15/2005US20050277583 Histone deacetylase inhibitors and process for producing the same
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005US20050276764 Topical use of bis-arylimidazo[1,2-a]thiolane derivatives
12/15/2005DE102004026669A1 Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels Use of a combination of ethinyl estradiol and chlormadinone acetate in the manufacture of a medicament
12/15/2005CA2569234A1 Composition for treatment of a hydrofluoric acid burn
12/15/2005CA2568780A1 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005CA2562332A1 Amino-propanol derivatives
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604672A1 Method of transdermal and transmucosal absorption of carbon dioxide and cosmetic method and therapeutic method
12/14/2005EP1604646A1 Viscous compositions containing carbon dioxide
12/14/2005EP1604645A1 Viscous compositions containing carbon dioxide
12/14/2005EP1603917A1 Immunomodulating heterocyclic compounds
12/14/2005EP1603594A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1065